GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Open accessThe DOI matches its Crossref record; 213 of the 216 references it cites were found in a registry or an index.
Abstract
The intestine represents the body’s largest interface between internal organs and external environments except for its nutrient and fluid absorption functions. It has the ability to sense numerous endogenous and exogenous signals from both apical and basolateral surfaces and respond through endocrine and neuronal signaling to maintain metabolic homeostasis and energy expenditure. The intestine also harbours the largest population of microbes that interact with the host to maintain human health and diseases. Furthermore, the gut is known as the largest endocrine gland, secreting over 100 peptides and other molecules that act as signaling molecules to regulate human nutrition and physiology. Among these gut-derived hormones, glucagon-like peptide 1 (GLP-1) and -2 have received the most attention due to their critical role in intestinal function and food absorption as well as their application as key drug targets. In this review, we highlight the current state of the literature that has brought into light the importance of GLP-1 and GLP-2 in orchestrating intestine–microbiota–immune system crosstalk to maintain intestinal barrier integrity, inflammation, and metabolic homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, GLP-1 mitigates liver inflammation and fibrosis by inhibiting the NF-κB pathway, reducing the release of pro-inflammatory cytokines such as TNF-α and IL-6, and thus suppressing inflammatory pathways.307,413”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–213 of 213
Jeffrey, L. O. (2019) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410281 · Cited by 17
Deng, G., Lei, Q., Gao, X., Zhang, Y., Zheng, H., Bi, J., & Wang, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.688715 · Cited by 17
Li, D., Yang, Y., Yin, X., Liu, Y., Xu, H., Ni, Y., Hang, P., Niu, S., Zhang, H., Ding, W., et al. (2021) · Bioengineered · doi:10.1080/21655979.2021.1958600 · Cited by 16
Varin, E. M., Hanson, A. A., Beaudry, J. L., Nguyen, M.-A., Cao, X., Baggio, L. L., Mulvihill, E. E., & Drucker, D. J. (2020) · JCI Insight · doi:10.1172/jci.insight.140418 · Cited by 15
Mutational Landscape of the Proglucagon-Derived Peptides
Lindquist, P., Madsen, J. S., Bräuner‐Osborne, H., ROSENKILDE, M. M., & Hauser, A. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.698511 · Cited by 14
Sasaki‐Hamada, S., Fujiwara, A., Satoh, S., Iwai, T., & Oka, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113235 · Cited by 12
T-Cell Activation in the Curious World of the Intestinal Intraepithelial Lymphocyte
Klein, J. R. (2004) · Immunologic Research · doi:10.1385/ir:30:3:327 · Cited by 11
Zhang, Q., Liu, M., Li, S., Xu, Z., Wang, J., Wang, Y., Fei, Z., Huang, W., & Sun, H. (2018) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2018.01.002 · Cited by 10
Sun, H., Meng, K., Hou, L., Shang, L., & Yan, J. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113253 · Cited by 8
Glerup, P., Sonne, K., Berner-Hansen, M. A., & Skarbaliene, J. (2022) · Physiological Research · doi:10.33549/physiolres.934839 · Cited by 5
Velázquez, E., Blázquez, E., & Ruiz‐Albusac, J. M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8298-1 · Cited by 4
Wang, C., Fan, W., Feng, X., Zhang, Y., Liu, C., & Liu, Z. (2021) · PubMed Central · Cited by 4
Pang, J., Feng, J. N., Ling, W., et al. (2021) · doi:10.22541/au.163913208.81687299/v1 · Cited by 2
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“307,413 In terms of apoptosis inhibition, GLP-1 activates the PI3K/Akt signaling pathway, enhances the expression of the anti-apoptotic protein Bcl-2, and inhibits the activation of caspase family proteins, reducing cell apoptosis.”
BackgroundSahoo, D. K., Heilmann, R. M., Paital, B., Patel, A., Yadav, V. K., Wong, D., & Jergens, A. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217165 · Cited by 339
Pillai, S. S., Gagnon, C. A., Foster, C., & Ashraf, A. P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae499 · Cited by 199
The intestine as an endocrine organ and the role of gut hormones in metabolic regulation
Bany Bakar, R., Reimann, F., & Gribble, F. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00830-y · Cited by 144
A Comprehensive Review of the Triangular Relationship among Diet–Gut Microbiota–Inflammation
Randeni, N., Bordiga, M., & Xu, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179366 · Cited by 127
Metadata
- Authors
- Abdalqadir, N., & Adeli, K.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Adeli, Khosrow
- ORCID
- Adeli, Khosrow
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2022-10-19
- Volume
- 10
- Issue
- 10
- Pages
- 2061
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC9610230
- OpenAlex
- W4306848286
- Cited by
- 119
- References
- 216
- Citations by year
- 2026: 36 · 2025: 38 · 2024: 36 · 2023: 8 · 2022: 1
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institute of Health Research (CIHR) (FDN-148396)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- glucagon-like peptide-1, glucagon-like peptide-2, intestinal barrier integrity, gut microbiota, intestinal immunity, gut-brain-microbiota axis, intestinal inflammation, metabolic homeostasis, gastrointestinal hormones, intestinal endocrine cells, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.